An approach for screening solvent systems for PSCs to substitute REACH restricted DMF with no loss in device performance.
No takes yet. Share an insight, caveat, or question.
Doolin et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: